Clinical Trial Update: Prolactin Receptor and Breast Diseases

View source ↗

Summary

A completed clinical trial investigating prolactin receptor–targeting approaches in benign breast disease and breast cancer has been reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Breast Disease
• Breast Cancer

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Benign Breast Disease, Breast Cancer | Status: COMPLETED